Soreskog E, Lindberg I, Kanis JA, Akesson KE, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden. Osteoporos Int 2021 Jan 6. pii: 10.1007/s00198-020-05780.
PMID: 33409591